Scarica l'app Stockscreener
103.16
0.60%
-0.62
Pre-mercato:
103.30
0.14
+0.14%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Boston Scientific Corp Borsa (BSX) Ultime notizie
Boston Scientific Q2 2025 slides: 22.8% sales growth fueled by Electrophysiology surge - Investing.com
Boston Scientific trumps top and bottom-line forecasts, issues upbeat 2025 guide - Investing.com
Boston Scientific earnings beat by $0.02, revenue topped estimates - Investing.com UK
Boston Scientific announces results for second quarter 2025 - Financial Times
Is Boston Scientific Corporation a good long term investmentRobust investment performance - jammulinksnews.com
Boston Scientific (BSX) Anticipates Robust Q2 Earnings Growth - GuruFocus
FDA expands Boston Sci’s Watchman label to post-ablation - BioWorld MedTech
Raymond James maintains Strong Buy on Boston Scientific stock - Investing.com
Boston Scientific Watchman wins FDA expansion for post-ablation patients - MassDevice
Boston Scientific stock set to beat Q2 estimates, says TD Cowen - Investing.com
Boston Scientific: Strong Growth Potential and Positive Outlook Justify Buy Rating - TipRanks
What analysts say about Boston Scientific Corporation stockBreakthrough stock performance - printweek.in
Exploring Analyst Estimates for Boston Scientific (BSX) Q2 Earnings, Beyond Revenue and EPS - Yahoo Finance
Boston Scientific Corp (BSX) Secures FDA Labeling Expansion for FARAPULSE Pulsed Field Ablation (PFA) System - MSN
Boston Scientific’s Innovation Drive Keeps The Stock Climbing - Finimize
Lobbying Update: $570,000 of BOSTON SCIENTIFIC CORPORATION lobbying was just disclosed - Nasdaq
Boston Scientific (BSX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Is Boston Scientific Corporation (NYSE:BSX) Worth US$103 Based On Its Intrinsic Value? - Yahoo Finance
Will Robust MedSurg Performance Fuel Boston Scientific's Q2 Earnings? - MSN
Boston Scientific receives US FDA approval for expanded labelling of Farapulse pulsed field ablation system - Cardiac Rhythm News
Boston Scientific (BSX): A High-Stakes Gamble on Innovation Ahead of Q2 Earnings - AInvest
Why Boston Scientific (BSX) Outpaced the Stock Market Today - Yahoo Finance
Prostate Care Market Report 2025-2031 | Medtronic, Johnson & Johnson, Boston Scientific, and Abbott Laboratories Dominate through Product Innovations, Clinical Trials, M&As, and Strategic Partnerships - Yahoo Finance
13 Best Large Cap Stocks to Buy Right Now - Insider Monkey
Boston Scientific’s (BSX) FARAPULSE Approved by FDA for Expanded Labeling - Insider Monkey
Boston Scientific (BSX) Crossed Above the 20-Day Moving Average: What That Means for Investors - Yahoo Finance
Here's How Much a $1000 Investment in Boston Scientific Made 10 Years Ago Would Be Worth Today - Yahoo Finance
North America Ureteroscopes Market Outlook Report 2018-2033 with an Overview of Key CompaniesBoston Scientific, KARL STORZ, Olympus, PENTAX Medical, and Richard Wolf - Yahoo Finance
NICE recommends pulsed field ablation tech for AFib - MassDevice
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance
Is It Worth Adding Boston Scientific Stock To Your Portfolio Now? - Barchart.com
Is it Worth Adding Boston Scientific Stock to Your Portfolio Now? - Yahoo Finance
Boston Scientific (BSX) Receives a Buy from Citi - The Globe and Mail
Boston Scientific (BSX) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Boston Scientific Gets FDA Nod for Expanded Labeling of Pulsed Field Ablation System - Diagnostic and Interventional Cardiology
Boston Scientific gets expanded PFA label for persistent AFib - MedTech Dive
FDA greenlights Boston Sci’s Farapulse for persistent AF - BioWorld MedTech
How Unusual Options Standout Boston Scientific (BSX) Is Signaling A Statistical Edge - Barchart.com
Boston Scientific stock rises as TD Cowen reiterates Buy rating - Investing.com
Boston Scientific (NYSE:BSX) Expands FARAPULSE System FDA Approval For Persistent Atrial Fibrillation - Yahoo Finance
Boston Scientific wins expanded FDA nod for Farapulse PFA - MassDevice
Boston Scientific’s PFA system gets FDA approval for persistent AF - Investing.com
Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System - Financial Times
What to Expect From Boston Scientific's Next Quarterly Earnings Report - MSN
Boston Scientific Sues Stryker Over Back Pain Treatment Patent - Bloomberg Law News
Feds Subpoena Boston Scientific Over BridgePoint Deal - Law.com
Will Boston Scientific (BSX) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Boston Scientific Q2 2025 Earnings: CEO and CFO to Present Full Financial Results July 23 - Stock Titan
Boston Scientific stock hits all-time high at 107.2 USD - Investing.com
Boston Scientific (BSX) Gains Momentum Amid Study Pause on Rival Device | BSX Stock News - GuruFocus
Does Boston Scientific (NYSE:BSX) Have A Healthy Balance Sheet? - Yahoo Finance
24-Acre Minnetonka Complex Put Up for Sale by Boston Scientific (BSX) - Insider Monkey
2.02%
0.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):